Shares of Eisai and Partner Biogen Have Soared Since Reporting That Their Drug Lecanemab ... - Latest Tweet by Bloomberg
The latest Tweet by Bloomberg states, 'Shares of Eisai and partner Biogen have soared since reporting that their drug lecanemab slowed Alzheimer’s, the first to unambiguously impede the progression of the disease in a final-stage trial. But many questions linger ...'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)